MozafariGroup

Who We Are

Masoud Mozafari, PhD

The MozafariGroup, led by Dr. Masoud Mozafari, is dedicated to advancing biomaterials research with a focus on creating advanced smart biomaterials that support precision medicine. At the MozafariGroup, the team develops biomaterials designed to interact with the body in a controlled, targeted way—responding to specific biological signals for more personalized treatment.

Dr. Mozafari is currently an affiliated visiting professor at the University of Oulu, Finland, and has previously held a fellowship at Mount Sinai Hospital and the University of Toronto, Canada. He has been awarded the Khwarizmi International Award and the Julia Polak European Doctorate Award for his impactful work in biomaterials. Additionally, he received the WIPO Medal for Inventors from the World Intellectual Property Organization (WIPO) – the United Nations (UN).

Dr. Mozafari actively shapes the field through his editorial roles, including on the Advisory Board of ACS Biomaterials Science and Engineering. Under his leadership, the MozafariGroup focuses on transforming scientific discoveries into practical applications, setting new standards in biomaterials that are tailored to respond dynamically to the body’s biological signals. His vision for precision medicine is driving new advancements that hold the potential to reshape modern healthcare.

Mission & Vision

Our mission is to tackle major health challenges by developing next-generation smart biomaterials that drive the future of precision medicine. We focus on creating biomaterials that interact seamlessly with the body, adapting to unique biological signals to improve health outcomes and elevate the quality of life. With a vision to redefine healthcare, we are committed to transforming innovative scientific ideas into impactful technologies, bridging the gap between research and real-world application, and setting new standards in biomaterials for a healthier tomorrow.

Strategic Priorities and Guiding Principles

Next-Generation Biomaterials

Developing advanced biomaterials to tackle healthcare challenges.

Precision Medicine

Creating biomaterials that enable tailored treatments based on individual biological profiles.

Innovation and Technology

Leveraging cutting-edge technology to create practical applications from scientific research.

Enhanced Patient Care

Designing biomaterials that improve clinical outcomes and support effective treatments.

Members

Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative.

Michael Monroe
Staff

Leverage agile frameworks to provide a robust synopsis for high level overviews.

Jason Moore
Staff

Leverage agile frameworks to provide a robust synopsis for high level overviews.

Nadin Simson
Staff

Leverage agile frameworks to provide a robust synopsis for high level overviews.

WE IN TOUCH

Have Any Questions?

Have a question or an idea? We welcome collaborative thinking and are excited to explore new insights together in the field of biomaterials science and engineering.

Learn About Us